Use of cancer stem cells to investigate the pathogenesis of colitis-associated cancer

Julie M. Davies, Rebeca Santaolalla, Maria T Abreu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Colitis-associated cancer (CAC) can develop in patients with inflammatory bowel disease with long-term uncontrolled inflammation. The mutational history and tumor microenvironment observed in CAC patients is distinct from that observed in sporadic colon cancer and suggests a different etiology. Recently, much attention has been focused on understanding the cellular origin of cancer and the cancer stem cells, which is key to growth and progression. Cancer stem cells are often chemo-resistant making them attractive targets for improving patient outcomes. New techniques have rapidly been evolving allowing for a better understanding of the normal intestinal stem cell function and behavior in the niche. Use of these new technologies will be crucial to understanding cancer stem cells in both sporadic and CAC. In this review, we will explore emerging methods related to the study of normal and cancer stem cells in the intestine, and examine potential avenues of investigation and application to understanding the pathogenesis of CAC.

Original languageEnglish (US)
Pages (from-to)976-983
Number of pages8
JournalInflammatory Bowel Diseases
Volume22
Issue number4
DOIs
StatePublished - Mar 9 2016

Fingerprint

Neoplastic Stem Cells
Colitis
Neoplasms
Tumor Microenvironment
Inflammatory Bowel Diseases
Colonic Neoplasms
Intestines
Stem Cells
History
Inflammation
Technology
Growth

Keywords

  • APC
  • colitis-associated cancer
  • colonoid
  • enteroid
  • inflammation
  • Lgr5
  • stem cells
  • β-catenin

ASJC Scopus subject areas

  • Gastroenterology
  • Immunology and Allergy

Cite this

Use of cancer stem cells to investigate the pathogenesis of colitis-associated cancer. / Davies, Julie M.; Santaolalla, Rebeca; Abreu, Maria T.

In: Inflammatory Bowel Diseases, Vol. 22, No. 4, 09.03.2016, p. 976-983.

Research output: Contribution to journalArticle

@article{9337fcb903af497e8fd45b26bd82b3c6,
title = "Use of cancer stem cells to investigate the pathogenesis of colitis-associated cancer",
abstract = "Colitis-associated cancer (CAC) can develop in patients with inflammatory bowel disease with long-term uncontrolled inflammation. The mutational history and tumor microenvironment observed in CAC patients is distinct from that observed in sporadic colon cancer and suggests a different etiology. Recently, much attention has been focused on understanding the cellular origin of cancer and the cancer stem cells, which is key to growth and progression. Cancer stem cells are often chemo-resistant making them attractive targets for improving patient outcomes. New techniques have rapidly been evolving allowing for a better understanding of the normal intestinal stem cell function and behavior in the niche. Use of these new technologies will be crucial to understanding cancer stem cells in both sporadic and CAC. In this review, we will explore emerging methods related to the study of normal and cancer stem cells in the intestine, and examine potential avenues of investigation and application to understanding the pathogenesis of CAC.",
keywords = "APC, colitis-associated cancer, colonoid, enteroid, inflammation, Lgr5, stem cells, β-catenin",
author = "Davies, {Julie M.} and Rebeca Santaolalla and Abreu, {Maria T}",
year = "2016",
month = "3",
day = "9",
doi = "10.1097/MIB.0000000000000756",
language = "English (US)",
volume = "22",
pages = "976--983",
journal = "Inflammatory Bowel Diseases",
issn = "1078-0998",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Use of cancer stem cells to investigate the pathogenesis of colitis-associated cancer

AU - Davies, Julie M.

AU - Santaolalla, Rebeca

AU - Abreu, Maria T

PY - 2016/3/9

Y1 - 2016/3/9

N2 - Colitis-associated cancer (CAC) can develop in patients with inflammatory bowel disease with long-term uncontrolled inflammation. The mutational history and tumor microenvironment observed in CAC patients is distinct from that observed in sporadic colon cancer and suggests a different etiology. Recently, much attention has been focused on understanding the cellular origin of cancer and the cancer stem cells, which is key to growth and progression. Cancer stem cells are often chemo-resistant making them attractive targets for improving patient outcomes. New techniques have rapidly been evolving allowing for a better understanding of the normal intestinal stem cell function and behavior in the niche. Use of these new technologies will be crucial to understanding cancer stem cells in both sporadic and CAC. In this review, we will explore emerging methods related to the study of normal and cancer stem cells in the intestine, and examine potential avenues of investigation and application to understanding the pathogenesis of CAC.

AB - Colitis-associated cancer (CAC) can develop in patients with inflammatory bowel disease with long-term uncontrolled inflammation. The mutational history and tumor microenvironment observed in CAC patients is distinct from that observed in sporadic colon cancer and suggests a different etiology. Recently, much attention has been focused on understanding the cellular origin of cancer and the cancer stem cells, which is key to growth and progression. Cancer stem cells are often chemo-resistant making them attractive targets for improving patient outcomes. New techniques have rapidly been evolving allowing for a better understanding of the normal intestinal stem cell function and behavior in the niche. Use of these new technologies will be crucial to understanding cancer stem cells in both sporadic and CAC. In this review, we will explore emerging methods related to the study of normal and cancer stem cells in the intestine, and examine potential avenues of investigation and application to understanding the pathogenesis of CAC.

KW - APC

KW - colitis-associated cancer

KW - colonoid

KW - enteroid

KW - inflammation

KW - Lgr5

KW - stem cells

KW - β-catenin

UR - http://www.scopus.com/inward/record.url?scp=84962269057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962269057&partnerID=8YFLogxK

U2 - 10.1097/MIB.0000000000000756

DO - 10.1097/MIB.0000000000000756

M3 - Article

C2 - 26963566

AN - SCOPUS:84962269057

VL - 22

SP - 976

EP - 983

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

SN - 1078-0998

IS - 4

ER -